Anavex Life Sciences Corp. (LON:0HFR)
London · Delayed Price · Currency is GBP · Price in USD 3.895
+0.014 (0.35%)
Feb 12, 2026, 4:56 PM GMT
Anavex Life Sciences Market Cap
Anavex Life Sciences has a market cap or net worth of 266.68 million as of February 12, 2026. Its market cap has decreased by -60.54% in one year.
Market Cap
266.68M
Enterprise Value
169.96M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
3.90
Market Cap Chart
Since April 13, 2006, Anavex Life Sciences's market cap has increased from 182.56K to 266.68M, an increase of 145,979.01%. That is a compound annual growth rate of 44.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 263.53M | 11.51% |
| Dec 31, 2025 | 236.33M | -67.52% |
| Dec 31, 2024 | 727.61M | 21.27% |
| Dec 29, 2023 | 599.98M | 0.14% |
| Dec 30, 2022 | 599.16M | -38.45% |
| Dec 31, 2021 | 973.48M | 267.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 11.10B |
| PureTech Health | 311.77M |
| NIOX Group | 272.49M |
| Avacta Group | 260.26M |
| Integrated Diagnostics Holdings | 259.90M |